Triangular Invariant Sets for Containment of Drug Resistance Under Evolutionary Therapy
Abstract
Evolutionary therapies regulate heterogeneous populations by altering selective pressures through treatment sequences in cancer and infections. This letter develops an invariant-set framework for treatment-induced containment based on positive triangular invariant sets. For periodically switched systems, sufficient conditions are derived for the existence of such invariant regions. Robustness with respect to mutation is established by showing that the invariant simplex persists under small perturbations of the subsystem matrices. In the two-phenotype case, the analysis yields an explicit mutation threshold that separates regimes in which therapy cycling maintains containment from regimes in which mutation can enable evolutionary escape. Simulations illustrate the geometry of the invariant sets and the role of mutation and dwell time in containment robustness.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies
J. A. Gallaher, P. M. Enriquez-Navas, … A. R. A. Anderson·bioRxiv·Sep 8, 2017
- The logic of containing tumors
Y. Viossat, R. J. Noble·bioRxiv·Jan 22, 2020
- Spatial resource dynamics control resistance escape
Nico Appold, Timon Citak, … Jona Kayser·bioRxiv·Feb 26, 2026
- Drug-induced resistance evolution necessitates less aggressive treatment
T. Kuosmanen, J. Cairns, … V. Mustonen·bioRxiv·Oct 7, 2020
- Cancer Evolvability Determines Therapy Outcomes
Ranjini Bhattacharya, Anuraag Bukkuri, … Joel S. Brown·Evolutionary ApplicationsPeer-reviewed·Oct 1, 2026
- Towards multi-drug adaptive therapy
J. West, L. You, … A. R. Anderson·bioRxiv·Jul 25, 2019